Literature DB >> 1857500

Mental planning and anticipatory processes with acute and chronic frontal lobe lesions: a comparison of maze performance in routine and non-routine situations.

H O Karnath1, C W Wallesch, P Zimmermann.   

Abstract

A series of computerized mazes were masked during presentation allowing only partial view of their structure. Patients suffering from acute or chronic unilateral frontal (medial, lateral) or retrorolandic (temporal, parietal) lesions and non-brain-damaged controls were required to pass through the mazes repeatedly, until they solved them without reaching a dead end. Because the mazes could not be viewed in their entirety at any one time, the subjects were forced to mentally generate and apply a plan of the maze. The first ("non-routine" situation), the second and the last ("routine" situation) trials of the mazes were analysed separately. The prefrontal cortex is supposed to subserve important functions in the planning of behaviour in unfamiliar, non-routine situations. Shallice (Phil. Trans. R. Soc. Lond. B298, 199-209, 1982; From Neuropsychology to Mental Structure, Cambridge University Press, Cambridge, 1988) therefore postulated that the behaviour of patients with frontal lobe lesions should not be disturbed in routine situations, but rather these patients should exhibit difficulties in dealing with new and unfamiliar situations. In the present investigation, patients with acute and chronic frontomedial lesions exhibited deficits in generating mental plans. Patients with acute frontomedial lesions made a larger number of errors in their second trials and subsequently required more trials to reach task criterium. Patients with chronic frontomedial lesions showed more frequent rule-breaking behaviour in their second trials. The analysis of maze performance in the first trial and that trial in which task criterion was achieved, showed that frontal lobe patients were impaired in neither routine nor non-routine situations. The observed results suggest a modification concerning Shallice's assumptions. Patients with frontomedial lesions are not generally incapable of dealing with non-routine situations. But they seem to be slower than patients with retrorolandic lesions and controls in profiting from experiences made in an unfamiliar, non-routine situation represented by the first explorations of new maze problems. This deficit can possibly be explained by the observation that anticipatory processes or the formation of expectations about possibly correct decisions in non-routine situations were altered in acute and chronic frontomedial patients. When these patients reached a maze intersection for the first time and therefore had no information about the continuation of the correct path, they showed significantly different intuitive directional decisions when compared to controls.

Entities:  

Mesh:

Year:  1991        PMID: 1857500     DOI: 10.1016/0028-3932(91)90042-7

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  4 in total

Review 1.  Behavior at the choice point: decision making in hidden pathway maze learning.

Authors:  Elizabeth Thomas; Peter J Snyder; Robert H Pietrzak; Paul Maruff
Journal:  Neuropsychol Rev       Date:  2014-10-28       Impact factor: 7.444

2.  Executive functioning, irritability, and alcohol-related aggression.

Authors:  Aaron J Godlaski; Peter R Giancola
Journal:  Psychol Addict Behav       Date:  2009-09

3.  Is the prefrontal cortex necessary for establishing cognitive sets?

Authors:  James B Rowe; Katsuyuki Sakai; Torben E Lund; Thomas Ramsøy; Mark Schram Christensen; William F C Baare; Olaf B Paulson; Richard E Passingham
Journal:  J Neurosci       Date:  2007-11-28       Impact factor: 6.167

4.  Disorganized behavior on Link's cube test is sensitive to right hemispheric frontal lobe damage in stroke patients.

Authors:  Bruno Kopp; Nina Rösser; Sandra Tabeling; Hans Jörg Stürenburg; Bianca de Haan; Hans-Otto Karnath; Karl Wessel
Journal:  Front Hum Neurosci       Date:  2014-02-17       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.